Announce the Phase 1 clinical trial data of SNS812 a broad-spectrum antiviral siRNA for COVID-19 developed jointly by Microbio (Shanghai) Co.,Ltd. and Oneness.

Approved the removal of restrictions imposed against the manager for involving in competing businesses by the BOD.

To announce 2023 Shareholders’ Meeting majoy resolutions.

Approved the removal of restrictions imposed against the director for involving in competing businesses by the 2023 Shareholders’ meeting.